Loading…

Dendritic cells and differential usage of the MHC class II transactivator promoters in the central nervous system in experimental autoimmune encephalitis

In the normal central nervous system (CNS) expression of MHC class II is minimal, but has been found to be highly up‐regulated on microglia cells in experimental autoimmune encephalitis (EAE). Here we used the EAE model to examine the regulation of expression of the class II transactivator (CIITA),...

Full description

Saved in:
Bibliographic Details
Published in:European journal of immunology 2000-03, Vol.30 (3), p.794-802
Main Authors: Suter, Tobias, Malipiero, Ursula, Otten, Luc, Ludewig, Burkhard, Muelethaler‐Mottet, Annick, Mach, Bernard, Reith, Walter, Fontana, Adriano
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In the normal central nervous system (CNS) expression of MHC class II is minimal, but has been found to be highly up‐regulated on microglia cells in experimental autoimmune encephalitis (EAE). Here we used the EAE model to examine the regulation of expression of the class II transactivator (CIITA), which is required for activation of MHC class II genes. EAE was induced in C57BL / 6 mice by immunization with myelin oligodendrocyte glycoprotein peptide 35 – 55. CIITA mRNA form I (specific for dendritic cells) and form IV (IFN‐γ inducible) but not form III (B cell specific) were detected in brain and spinal cord of mice with acute EAE. In unimmunized or mock‐immunized mice, none of the three CIITA forms was found to be induced. Dendritic cells (DC) were identified by immunostainings for CD11c in perivascular and meningeal cell infiltrates in EAE spinal cord and brain. Time‐course analysis showed (1) the appearance of DC in the CNS shortly before onset of disease, (2) the recruitment of CD11b+ cells occuring much earlier and (3) the absence of CIITA and MHC class II expression in these CD11b+ cells at preclinical stages.
ISSN:0014-2980
1521-4141
DOI:10.1002/1521-4141(200003)30:3<794::AID-IMMU794>3.0.CO;2-Q